Documents
Application Sponsors
NDA 019716 | MERCK SHARP DOHME | |
Marketing Status
Application Products
001 | LOTION, AUGMENTED;TOPICAL | EQ 0.05% BASE | 1 | DIPROLENE | BETAMETHASONE DIPROPIONATE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1988-08-01 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1989-04-06 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 1989-05-24 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 1990-08-01 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 1992-07-01 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2005-10-07 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 1996-01-25 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 1998-06-15 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 9 | AP | 1998-07-31 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 10 | AP | 1999-05-14 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 2000-09-07 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 12 | AP | 2001-05-11 | STANDARD |
LABELING; Labeling | SUPPL | 21 | AP | 2006-04-24 | STANDARD |
EFFICACY; Efficacy | SUPPL | 22 | AP | 2006-08-28 | STANDARD |
LABELING; Labeling | SUPPL | 30 | AP | 2014-08-13 | STANDARD |
LABELING; Labeling | SUPPL | 32 | AP | 2018-03-28 | STANDARD |
LABELING; Labeling | SUPPL | 33 | AP | 2019-05-01 | STANDARD |
Submissions Property Types
SUPPL | 2 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 5 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 8 | Null | 0 |
SUPPL | 9 | Null | 0 |
SUPPL | 10 | Null | 0 |
SUPPL | 11 | Null | 0 |
SUPPL | 12 | Null | 0 |
SUPPL | 30 | Null | 7 |
SUPPL | 32 | Null | 7 |
SUPPL | 33 | Null | 7 |
CDER Filings
MERCK SHARP DOHME
cder:Array
(
[0] => Array
(
[ApplNo] => 19716
[companyName] => MERCK SHARP DOHME
[docInserts] => ["",""]
[products] => [{"drugName":"DIPROLENE","activeIngredients":"BETAMETHASONE DIPROPIONATE","strength":"EQ 0.05% BASE","dosageForm":"LOTION, AUGMENTED;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"05\/01\/2019","submission":"SUPPL-33","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/019716s033lbl.pdf\"}]","notes":""},{"actionDate":"03\/28\/2018","submission":"SUPPL-32","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/019716s032lbl.pdf\"}]","notes":""},{"actionDate":"08\/13\/2014","submission":"SUPPL-30","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/019716s030lbl.pdf\"}]","notes":""},{"actionDate":"08\/28\/2006","submission":"SUPPL-22","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/019716s022lbl.pdf\"}]","notes":""},{"actionDate":"10\/07\/2005","submission":"SUPPL-6","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/019716s006lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"DIPROLENE","submission":"BETAMETHASONE DIPROPIONATE","actionType":"EQ 0.05% BASE","submissionClassification":"LOTION, AUGMENTED;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2019-05-01
)
)